-
The world's first oral administration of Smegglutide has been approved in China, and the GLP-1 drug market may face changes
Recently, the National Medical Products Administration (NMPA) released the latest drug approval documents, and Novo Nordisk's Smegglutide tablets have been officially approved for sale in China for t ...